iCardiac Technologies
iCardiac Technologies is a Rochester, U.S.-based laboratory founded in 2006 that develops cardiac safety biomarkers to assess drugs in development for pharmaceutical and biotechnology sponsors.
- Company typePrivate
- Founded2006
- HeadquartersRochester, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
iCardiac Technologies firmographics
Firmographics- Name
- iCardiac Technologies
- Legal name
- iCardiac Technologies
- Website
- https://icardiac.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- iCardiac Technologies is a Rochester, U.S.-based laboratory founded in 2006 that develops cardiac safety biomarkers to assess drugs in development for pharmaceutical and biotechnology sponsors.
- Ownership category
- akta.pro rank
iCardiac Technologies industry classification
Industry- Product category
- Cardiac Safety Laboratory Services
- NAICS
- Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG) (HLAGAAAJ)
Keywords
Where iCardiac Technologies is headquartered
LocationHeadquarters
- HQ city
- Rochester
- HQ country
- United States
- HQ region
- North America
Markets served
iCardiac Technologies business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
iCardiac Technologies product offering
Product offeringCore offering
iCardiac Technologies is a cardiac safety laboratory that develops and applies cardiac safety biomarkers to assess drugs in development. The company provides cardiac safety evaluations and biomarker-based analyses used by pharmaceutical and biotechnology sponsors during clinical drug development to characterize cardiac risk of investigational compounds.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiac Safety Biomarker Assessments
Companies that use iCardiac Technologies
Customer profileIdeal customer profiles1 record
iCardiac Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
iCardiac Technologies competitors and assessment
Company assessmentBroad incumbents
- Clario (formerly ERT): Clario is the largest dedicated cardiac safety core lab globally, offering ECG/Holter and imaging solutions for clinical trials. It is the most direct scaled competitor to iCardiac in cardiac safety core lab services for pharma sponsors.
- Medpace: Medpace is a mid-to-large full-service CRO with significant cardiovascular clinical trial capabilities. It competes with iCardiac by bundling cardiac safety endpoints into broader clinical operations offerings.
- IQVIA: IQVIA is one of the world's largest CROs and offers cardiac safety/QT services as part of its broader clinical development portfolio. Competes for the same pharma sponsor cardiac safety spend.
- ICON plc: ICON is a global CRO providing cardiac safety and ECG core lab services alongside broader clinical development capabilities. A scaled alternative for sponsors seeking one-stop-shop vendors.
- Charles River Laboratories: Charles River offers safety pharmacology and cardiovascular assessment services alongside broader preclinical and clinical offerings. Overlaps with iCardiac on the safety pharmacology/cardiac assessment side.
- Labcorp Drug Development (formerly Covance): Labcorp/Covance is a top-tier global CRO with cardiac safety core lab capabilities as part of its integrated clinical development platform. Competes for the same pharma cardiac safety contracts.
Emerging players
- BioClinica (now Clario): BioClinica (now part of Clario) provided imaging and cardiac safety core lab services to pharma sponsors. Direct overlap with iCardiac's cardiac safety core lab focus, especially for trials requiring cardiac imaging.
- Notch Therapeutics: Notch is an emerging biotech-adjacent cardiac safety/biomarker player with overlapping technical interests in cardiac risk assessment. Included as a thematic peer given overlap in cardiac biomarker focus.
Direct peers
- Celerion: Celerion is a specialized early-phase clinical research and cardiac safety core lab serving pharma/biotech sponsors. Closely comparable niche CRO with similar focus on thorough QT and early cardiac safety studies.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO with significant cardiovascular and safety pharmacology expertise. Comparable in scale and therapeutic focus to iCardiac, serving similar pharma/biotech sponsors.
Market position
Customer concentration
iCardiac Technologies social profiles
Digital presenceiCardiac Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
iCardiac Technologies leadership team
Management profileNumber of profiles
Profiles3 records
iCardiac Technologies funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iCardiac Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iCardiac Technologies
What does iCardiac Technologies do?
iCardiac Technologies is a cardiac safety laboratory that develops and applies cardiac safety biomarkers to assess drugs in development. The company provides cardiac safety evaluations and biomarker-based analyses used by pharmaceutical and biotechnology sponsors during clinical drug development to characterize cardiac risk of investigational compounds.
When was iCardiac Technologies founded?
iCardiac Technologies was founded in 2006. It employs 51 to 100 people.
Where is iCardiac Technologies based?
iCardiac Technologies is headquartered in Rochester, United States, in the North America region.
Who are iCardiac Technologies's main competitors?
Broad incumbents on record are Clario (formerly ERT), Medpace, IQVIA, ICON plc, Charles River Laboratories and Labcorp Drug Development (formerly Covance). Emerging players are BioClinica (now Clario) and Notch Therapeutics. Direct peers are Celerion and Worldwide Clinical Trials.
Does iCardiac Technologies have an API?
No public API is recorded for iCardiac Technologies.
What industry is iCardiac Technologies in?
iCardiac Technologies's product category is Cardiac Safety Laboratory Services. Its primary akta.pro industry code is HLAGAAAJ, Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG). Its NAICS code is 541690 and its SIC code is 8731.